File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Article: Clinical significance of angiogenesis in hepatocellular carcinoma
Title | Clinical significance of angiogenesis in hepatocellular carcinoma |
---|---|
Authors | |
Keywords | Angiogenesis Hepatocellular carcinoma Vascular endothelial growth factor |
Issue Date | 2003 |
Publisher | World Scientific Publishing Co Pte Ltd. The Journal's web site is located at http://www.worldscinet.com/cr/cr.shtml |
Citation | Cancer Reviews: Asia-Pacific, 2003, v. 1 n. 2, p. 167-178 How to Cite? |
Abstract | Hepatocellular carcinoma (HCC) is a hypervascular tumor characterized by neovascularization. Angiogenesis plays an important role in the growth and progression of HCC. Recent studies have indicated that assessment of angiogenic activity in HCC can provide prognostic information independent of conventional clinicopathological factors. Animal studies have demonstrated the efficacy of antiangiogenic agents in suppressing hepatocarcinogenesis and growth of HCC. Early clinical trials on the use of antiangiogenic agents in HCC have already been initiated. This article reviews the available literature on angiogenesis in HCC and discusses its potential clinical significance in the management of HCC.
Read More: http://www.worldscientific.com/doi/abs/10.1142/S0219836303000256 |
Persistent Identifier | http://hdl.handle.net/10722/84164 |
ISSN |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Poon, RTP | en_HK |
dc.date.accessioned | 2010-09-06T08:49:43Z | - |
dc.date.available | 2010-09-06T08:49:43Z | - |
dc.date.issued | 2003 | en_HK |
dc.identifier.citation | Cancer Reviews: Asia-Pacific, 2003, v. 1 n. 2, p. 167-178 | en_HK |
dc.identifier.issn | 0219-8363 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/84164 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is a hypervascular tumor characterized by neovascularization. Angiogenesis plays an important role in the growth and progression of HCC. Recent studies have indicated that assessment of angiogenic activity in HCC can provide prognostic information independent of conventional clinicopathological factors. Animal studies have demonstrated the efficacy of antiangiogenic agents in suppressing hepatocarcinogenesis and growth of HCC. Early clinical trials on the use of antiangiogenic agents in HCC have already been initiated. This article reviews the available literature on angiogenesis in HCC and discusses its potential clinical significance in the management of HCC. Read More: http://www.worldscientific.com/doi/abs/10.1142/S0219836303000256 | - |
dc.language | eng | en_HK |
dc.publisher | World Scientific Publishing Co Pte Ltd. The Journal's web site is located at http://www.worldscinet.com/cr/cr.shtml | en_HK |
dc.relation.ispartof | Cancer Reviews: Asia-Pacific | en_HK |
dc.rights | Cancer Reviews: Asia-Pacific. Copyright © World Scientific Publishing Co Pte Ltd. | - |
dc.subject | Angiogenesis | - |
dc.subject | Hepatocellular carcinoma | - |
dc.subject | Vascular endothelial growth factor | - |
dc.title | Clinical significance of angiogenesis in hepatocellular carcinoma | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Poon, RTP: poontp@hkucc.hku.hk | en_HK |
dc.identifier.authority | Poon, RTP=rp00446 | en_HK |
dc.identifier.doi | 10.1142/S0219836303000256 | - |
dc.identifier.hkuros | 87854 | en_HK |
dc.identifier.volume | 1 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 167 | - |
dc.identifier.epage | 178 | - |
dc.publisher.place | Singapore | - |
dc.identifier.issnl | 0219-8363 | - |